Fixed-Dose Trial in Early Parkinson's Disease (PD)

Clinical trial NCT04201093 · COMPLETED

Trial details

NCT number: NCT04201093
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2019-12-13
Primary completion: 2024-06-28
Enrollment: 529

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.